Editorial comment on “Wada N, Kita M, Hashizume K, et al. Urodynamic effects of dutasteride add-on therapy to alpha-adrenergic antagonist for patients with benign prostatic enlargement: Prospective pressure-flow study. Neurourol Urodyn 2013;32:1123–7”

Authors

  • Matthias Oelke

    Corresponding author
    1. Department of Urology, Hannover Medical School, Hannover, Germany
    • Correspondence to: Dr. Matthias Oelke, MD, FEBU, Associate Professor, Department of Urology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany.

      E-mail: oelke.matthias@mh-hannover.de

    Search for more papers by this author

  • Christopher Chapple led the peer-review process as the Associate Editor responsible for the paper.
  • Conflict of interest: Yes, The author is speaker and consultant of Astellas, GlaxoSmithKline (GSK), Lilly, Pfizer, and Recordati.

No abstract is available for this article.

Ancillary